Insight

Nazli Dizman: ICI rechallenge and future directions in mRCC

Photo taken from Nazli Dizman/X

May 21, 2024, 07:30

Nazli Dizman: ICI rechallenge and future directions in mRCC

Nazli Dizman, a Hematology/Oncology Fellow at MD Anderson Cancer Center, shared a post by The American Society of Clinical Oncology (ASCO) on X, adding:

“Check out our ASCO Daily News article on ICI rechallenge and future directions in mRCC with Toni Choueiri, Emre Yekedüz, and Marc Machaalani.

Really appreciate ASCO for this opportunity.”

Quoting ASCO’s post:

“For ASCO Daily News Toni Choueiri, Nazli Dizman, Marc Machaalani, andEmre Yekedüz examine recent/ongoing research efforts exploring IO rechallenge after prior ICI exposure to understand its potential in mRCC.”

mRCC

Additional information.
Source: Nazli Dizman/X and ASCO/X

ASCO ASCO Daily News cancer Emre Yekedüz ICI exposure ICI rechallenge ith Toni Choueiri Marc Machaalani MD Anderson Cancer Center mRCC Nazli Dizman OncoDaily Oncology the American Society of Clinical Oncology

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage